How Is Celiac Disease Diagnosed? Blood Tests, Biopsy, and What to Expect

The diagnosis of celiac disease has been transformed substantially over recent decades. What was once a condition recognized primarily in children with classic gastrointestinal symptoms is now identified across all ages with diverse clinical presentations. The development of highly accurate blood tests has revolutionized initial evaluation, allowing identification of patients who warrant further investigation through relatively simple testing. The combination of these blood tests with intestinal biopsy when needed provides definitive diagnosis for the substantial majority of patients. Understanding this diagnostic process helps patients navigate evaluation effectively and supports appropriate medical decisions.

The accuracy of celiac disease diagnosis matters substantially. The condition requires lifelong strict avoidance of gluten as the only effective treatment. Starting a gluten-free diet without proper diagnosis can produce two specific problems. First, it may make subsequent diagnostic testing inaccurate, as the antibodies that support diagnosis decrease with gluten avoidance. Second, it commits patients to a restrictive lifelong diet that may not actually be necessary if they do not have celiac disease. The implications support completing diagnostic testing before starting a gluten-free diet rather than reversing this order.

The diagnostic process typically follows a structured sequence. Clinical suspicion based on symptoms or risk factors prompts initial evaluation. Blood tests measuring specific antibodies provide highly accurate screening. For most patients with positive blood tests, intestinal biopsy provides definitive confirmation. The combination of these elements supports accurate diagnosis for the substantial majority of patients. Various special situations including specific patient populations and atypical presentations may require modified approaches.

The crucial element throughout the diagnostic process is continued gluten consumption. The blood tests measure antibodies produced in response to ongoing gluten exposure. The intestinal biopsy identifies damage from ongoing gluten exposure. Both can show false negative results in patients who have already started gluten avoidance. Patients suspected of having celiac disease should generally continue normal gluten consumption until evaluation is complete unless directed otherwise.

This article explains the celiac disease diagnostic process. It identifies who should be tested, examines the various blood tests used, discusses intestinal biopsy and what to expect, addresses interpretation of results, and frames practical aspects of evaluation. The understanding supports informed engagement with this important diagnostic process.

For broader context on celiac disease, see Celiac Disease: Symptoms, Diagnosis, Gluten-Free Diet, and Long-Term Management (Complete Guide).

⸻

Who Should Be Tested

Several groups warrant consideration of celiac disease testing.

Patients With Symptoms

Patients with symptoms suggestive of celiac disease warrant testing. The symptoms vary widely:

• Classic gastrointestinal symptoms including chronic diarrhea, abdominal pain, bloating, weight loss, and various others.
• Less obvious symptoms including fatigue, iron deficiency anemia, recurrent canker sores, infertility, neurological symptoms, joint pain, skin rashes (particularly dermatitis herpetiformis), and various others.

For more on symptoms, see Symptoms of Celiac Disease in Adults and Children.

Children With Failure to Thrive

Children with failure to thrive, growth delays, or various other concerning patterns warrant testing.

Patients With Family History

First-degree relatives (parents, siblings, children) of celiac disease patients have approximately 1 in 10 risk of also having the condition. Testing is reasonable for these individuals.

Patients With Associated Autoimmune Conditions

Various autoimmune conditions are associated with celiac disease, including type 1 diabetes, autoimmune thyroid disease, and various others. Patients with these conditions warrant consideration of celiac testing.

Patients With Iron Deficiency Anemia

Iron deficiency anemia, particularly when not explained by other causes, can be the only finding in some celiac disease patients. Testing addresses this possibility.

Patients With Osteoporosis

Osteoporosis at unusual ages or without other risk factors can suggest celiac disease.

Patients With Recurrent Pregnancy Loss

Various reproductive issues can be associated with celiac disease.

Down Syndrome and Various Other Conditions

Patients with Down syndrome, Turner syndrome, Williams syndrome, and various other genetic conditions have higher celiac disease prevalence.

IgA Deficiency

Patients with IgA deficiency have higher celiac disease prevalence and require modified testing approaches.

⸻

The Importance of Continued Gluten Consumption

A crucial element of celiac disease testing is continued gluten consumption during the evaluation.

Why Continued Consumption Matters

The diagnostic tests measure responses to gluten. Without ongoing gluten exposure, the tests can produce false negative results:

• Antibodies measured by blood tests decrease with gluten avoidance. After several weeks to months of avoidance, antibodies may become undetectable even in patients with celiac disease.
• Intestinal damage assessed by biopsy improves with gluten avoidance. After weeks to months, intestinal histology may appear normal in patients with celiac disease who have been avoiding gluten.

Recommended Approach

The recommended approach is to continue normal gluten consumption until diagnostic evaluation is complete. For patients who have already started gluten avoidance and want diagnostic confirmation, a "gluten challenge" reintroducing gluten for several weeks before testing may be needed.

Practical Considerations

Patients suspected of having celiac disease should generally not start gluten avoidance based on suspicion alone. Pursuing diagnostic confirmation first allows informed decisions.

For more on the gluten-free diet, see Gluten-Free Diet: What You Can and Cannot Eat with Celiac Disease.

⸻

Blood Tests

Blood tests provide the typical first step in celiac disease evaluation.

Tissue Transglutaminase IgA Antibody (tTG-IgA)

The tissue transglutaminase IgA antibody (tTG-IgA) is the primary screening test for celiac disease in patients with normal IgA levels. The test has high sensitivity (over 90 percent) and high specificity (over 95 percent) for celiac disease in patients consuming gluten. Positive tTG-IgA strongly suggests celiac disease and warrants further evaluation. Negative tTG-IgA in patients consuming gluten makes celiac disease unlikely but does not completely exclude it.

Total IgA

Total IgA testing is typically performed alongside tTG-IgA. Patients with selective IgA deficiency (a relatively common condition) cannot produce IgA antibodies, making IgA-based tests inaccurate for diagnosing celiac disease. For patients with low or absent IgA, IgG-based tests are used instead.

Anti-Endomysial IgA Antibody (EMA-IgA)

The anti-endomysial IgA antibody (EMA-IgA) is highly specific for celiac disease (approaching 100 percent specificity). The test is less commonly used than tTG-IgA due to subjective interpretation and higher cost. EMA-IgA may be used to confirm tTG-IgA results in some situations.

Deamidated Gliadin Peptide Antibodies

Deamidated gliadin peptide antibodies (DGP) including DGP-IgA and DGP-IgG can support diagnosis. The tests are particularly useful in young children where tTG-IgA sensitivity is somewhat lower. DGP-IgG is also useful in patients with IgA deficiency.

Total IgG-Based Tests

For patients with IgA deficiency, IgG-based tests including tTG-IgG and DGP-IgG are used.

HLA Genetic Testing

HLA genetic testing identifies HLA-DQ2 and HLA-DQ8 alleles. Approximately 95 percent of celiac patients have HLA-DQ2, and most others have HLA-DQ8. The genes are necessary but not sufficient for celiac disease. Many people with the genes never develop the condition. The test has primarily a negative predictive value. Patients without these genes essentially cannot develop celiac disease, supporting exclusion of the diagnosis.

The test is particularly useful for:

• Excluding celiac disease in patients with uncertain other test results.
• Evaluating family members at risk.
• Patients on gluten-free diets without prior diagnosis where reintroduction would be needed for other tests.

Approach to Initial Testing

For most patients, the initial evaluation includes tTG-IgA and total IgA. Additional tests are added based on results and clinical situation.

For more on hidden gluten, see Hidden Sources of Gluten: Foods That May Surprise You.

⸻

Intestinal Biopsy

Intestinal biopsy provides definitive diagnosis for most patients with positive blood tests.

Why Biopsy Is Important

Intestinal biopsy provides direct examination of the small intestinal lining. The technique allows assessment of the characteristic damage that defines celiac disease. The damage includes villous atrophy (flattening of the finger-like projections that increase surface area for nutrient absorption), crypt hyperplasia (lengthening of the crypts), and increased intraepithelial lymphocytes. The combination supports definitive diagnosis and assessment of disease severity.

How Biopsy Is Performed

Intestinal biopsy is typically performed during upper endoscopy (esophagogastroduodenoscopy or EGD). The procedure uses a flexible tube with a camera and instruments inserted through the mouth into the upper digestive tract. The procedure provides direct visualization and allows tissue samples to be obtained. Multiple samples (typically 4 to 6) are taken from various parts of the small intestine, particularly the duodenum and possibly duodenal bulb. The procedure is typically performed under sedation. Most patients have minimal discomfort during and after the procedure. The procedure typically takes 15 to 30 minutes. Most patients can return home within an hour or two after the procedure.

Marsh Classification

The findings on biopsy are typically classified using the Marsh-Oberhuber system.

• Marsh 0: Normal histology.
• Marsh 1: Increased intraepithelial lymphocytes only.
• Marsh 2: Increased intraepithelial lymphocytes plus crypt hyperplasia.
• Marsh 3 (subdivided into 3a, 3b, 3c): Various degrees of villous atrophy.

Marsh 3 changes typically represent definitive celiac disease findings. Marsh 1 and 2 changes can occur in celiac disease but can also reflect other conditions.

When Biopsy May Be Skipped

For some patients, biopsy may be skipped under specific circumstances. In children, the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines allow biopsy-free diagnosis when:

• tTG-IgA levels are at least 10 times the upper limit of normal.
• EMA-IgA is positive on a separate sample.
• The approach is supported by symptoms suggestive of celiac disease.

Biopsy-free diagnosis is more controversial in adults, with most experts recommending biopsy confirmation. For most adults, biopsy remains the gold standard for definitive diagnosis.

For more on long-term management, see Living with Celiac Disease: Daily Challenges and Practical Tips.

⸻

What to Expect During Endoscopy

Several specific aspects characterize the endoscopy experience.

Preparation

Preparation typically includes fasting for several hours before the procedure. Specific instructions are provided. Various medications may need adjustment before the procedure.

The Procedure

Most patients receive sedation during the procedure. The sedation typically includes a combination of medications providing both relaxation and amnesia. The procedure itself takes 15 to 30 minutes. Most patients have minimal awareness of the procedure due to sedation. The throat may feel slightly sore afterward.

Recovery

Recovery typically involves brief observation after the procedure. Most patients are alert enough to leave with a companion within an hour or two. Driving is not permitted on the day of the procedure due to sedation effects. Normal activities can typically resume the following day.

Risks

Endoscopy is generally a safe procedure. Risks include:

• Reactions to sedation.
• Bleeding from biopsy sites (uncommon and typically minor).
• Perforation (very rare).
• Various other rare complications.

Results

Biopsy results typically take several days to a week to be available. Discussion with the gastroenterologist addresses the findings and any next steps.

⸻

Interpretation of Results

Interpreting celiac disease test results involves several considerations.

Positive Blood Tests Plus Compatible Biopsy

Positive blood tests with compatible biopsy findings (typically Marsh 3) establish definitive celiac disease diagnosis.

Positive Blood Tests Without Biopsy Confirmation

Positive blood tests without biopsy confirmation suggest possible celiac disease. Biopsy is typically pursued for definitive diagnosis except in pediatric patients meeting specific criteria.

Negative Blood Tests

Negative blood tests in patients consuming gluten make celiac disease unlikely but do not completely exclude it. Some patients with celiac disease have negative blood tests, particularly those with mild disease or specific patterns. For patients with negative blood tests but high clinical suspicion, biopsy may be pursued anyway.

Negative Blood Tests Plus Negative HLA

Negative blood tests plus negative HLA-DQ2 and HLA-DQ8 essentially excludes celiac disease.

Discrepant Results

Discrepant results (positive blood tests with negative biopsy, or vice versa) require careful interpretation. Various factors can contribute including dietary status, sampling adequacy, and various others.

Already on Gluten-Free Diet

For patients already on gluten-free diets, evaluation is more challenging. Options include:

• HLA testing to exclude diagnosis if negative.
• Gluten challenge with reintroduction of gluten for several weeks before testing.
• Discussion with specialists about the best approach.

For more on related considerations, see Most Commonly Misdiagnosed Conditions.

⸻

Special Patient Populations

Several specific populations have particular diagnostic considerations.

Children

Children may show different patterns of celiac disease than adults. The biopsy-free diagnostic pathway is more accepted in children meeting specific criteria.

Adolescents

Adolescents face specific considerations including disease presentation patterns and the practical challenges of managing celiac disease at this age.

Adults

Most adults require biopsy for definitive diagnosis. The diagnostic approach typically includes blood tests followed by biopsy.

Older Adults

Celiac disease can present at any age including older adulthood. Comprehensive evaluation supports identification.

Patients With IgA Deficiency

IgA deficiency requires modified testing approaches using IgG-based tests instead of IgA-based tests.

Patients With Family History

Patients with first-degree relatives with celiac disease have approximately 1 in 10 risk. Periodic testing or testing when symptoms develop is reasonable.

Patients With Type 1 Diabetes

Patients with type 1 diabetes have approximately 1 in 20 risk of celiac disease. Periodic screening is recommended.

Patients With Down Syndrome and Other Conditions

Various conditions associated with celiac disease warrant periodic screening.

Patients With Dermatitis Herpetiformis

Dermatitis herpetiformis is essentially the skin manifestation of celiac disease. Diagnosis of dermatitis herpetiformis often establishes celiac disease.

⸻

After Diagnosis

After celiac disease diagnosis is established, several next steps follow.

Discussion of the Diagnosis

Discussion of the diagnosis with the patient and family supports understanding. The conversation addresses what celiac disease is, treatment options, and various other elements.

Initiation of the Gluten-Free Diet

The gluten-free diet is initiated after diagnosis. Working with a registered dietitian with celiac expertise provides essential guidance.

Evaluation for Complications

Evaluation for complications of celiac disease may be appropriate. The evaluations may include:

• Bone density testing for osteoporosis assessment.
• Iron, vitamin B12, vitamin D, and various other nutritional assessments.
• Liver function tests.
• Various other tests based on individual circumstances.

Family Member Evaluation

First-degree relatives warrant consideration of celiac disease testing given the increased prevalence.

Establishment of Follow-Up Care

Follow-up care monitors response to the gluten-free diet, addresses ongoing issues, and supports long-term management.

For more on long-term care, see Living with Celiac Disease: Daily Challenges and Practical Tips.

⸻

Common Misconceptions About Diagnosis

Several misconceptions about celiac disease diagnosis deserve attention.

Misconception: Symptoms Are Necessary for Diagnosis

Some celiac disease patients have minimal or no symptoms. Diagnosis can be made based on testing in asymptomatic patients with risk factors.

Misconception: Negative Symptoms Reaction to Gluten Excludes Celiac Disease

Some celiac disease patients have minimal acute symptoms after gluten exposure. The lack of dramatic symptoms does not exclude the diagnosis.

Misconception: Going Gluten-Free Is the Best Way to Test

Going gluten-free without testing makes diagnosis difficult or impossible. Continuing gluten consumption until testing is complete supports accurate diagnosis.

Misconception: Blood Tests Alone Are Sufficient

While blood tests are highly accurate, biopsy provides definitive diagnosis for most adult patients.

Misconception: One Negative Blood Test Excludes Celiac Disease

Some celiac patients have negative blood tests. Comprehensive evaluation may identify them despite negative initial tests.

Misconception: HLA Testing Diagnoses Celiac Disease

HLA testing has primarily a negative predictive value. Many people with the genes never develop celiac disease.

Misconception: Biopsy Is Always Difficult

Endoscopy with biopsy is generally well-tolerated. Modern sedation and techniques make the procedure straightforward for most patients.

⸻

Practical Aspects

Several practical aspects affect celiac disease evaluation.

Insurance Coverage

Insurance coverage for celiac testing varies. Most insurances cover the testing for patients with appropriate clinical indications.

Costs

Costs vary based on tests performed, insurance coverage, and various other factors. Discussion with healthcare providers and insurance addresses specific situations.

Time Frame

The diagnostic process typically takes weeks to months from initial evaluation to definitive diagnosis. The time involves obtaining blood tests, scheduling and performing endoscopy, and obtaining biopsy results.

Specialist Involvement

Gastroenterologist involvement is typical for celiac disease evaluation, particularly for endoscopy and biopsy. Some primary care providers initiate testing and refer to specialists when appropriate.

Follow-Up

Follow-up after diagnosis includes initiation of the gluten-free diet, dietitian consultation, and ongoing care.

For more on diagnostic complexity, see How Often Do Doctors Misdiagnose Patients?.

⸻

When to See a Specialist

Several types of specialists may be involved in celiac disease care.

• Primary care providers manage initial evaluation in many cases.
• Gastroenterologists, particularly those with celiac expertise, provide specialized evaluation, perform endoscopy and biopsy, and manage ongoing care.
• Registered dietitians with celiac expertise provide essential dietary guidance.
• Various other specialists may be involved depending on associated conditions or complications.

For complex situations including diagnostic uncertainty, severe symptoms, or various complications, evaluation at major medical centers with comprehensive celiac disease programs provides specialized expertise.

⸻

Conclusion

Celiac disease diagnosis requires a structured medical approach combining clinical suspicion, blood testing, and intestinal biopsy in most cases. Understanding this process helps patients navigate evaluation effectively.

Multiple groups warrant testing including patients with symptoms suggestive of celiac disease, children with failure to thrive, patients with family history, patients with associated autoimmune conditions, patients with iron deficiency anemia, patients with osteoporosis, and various others.

Continued gluten consumption during evaluation is critical. Stopping gluten before testing can produce false negative results.

Blood tests provide the typical first step. The tissue transglutaminase IgA antibody (tTG-IgA) is the primary screening test, with high sensitivity and specificity. Total IgA testing accompanies tTG-IgA. Various additional tests including EMA-IgA, DGP antibodies, and IgG-based tests for IgA-deficient patients support evaluation.

HLA genetic testing has primarily negative predictive value. Patients without HLA-DQ2 or HLA-DQ8 essentially cannot develop celiac disease.

Intestinal biopsy provides definitive diagnosis for most adults with positive blood tests. The biopsy is performed during upper endoscopy with multiple samples taken. The Marsh-Oberhuber classification grades findings.

For pediatric patients meeting specific criteria, biopsy-free diagnosis is acceptable using high-titer tTG-IgA plus positive EMA-IgA on a separate sample.

Endoscopy is generally well-tolerated. Sedation makes the procedure comfortable for most patients. Recovery is typically rapid.

Interpretation of results involves consideration of various scenarios. Discrepant or unclear results warrant careful evaluation.

Various special patient populations including children, adolescents, adults, older adults, patients with IgA deficiency, family members, patients with type 1 diabetes, patients with various associated conditions, and patients with dermatitis herpetiformis all have specific considerations.

After diagnosis, the gluten-free diet is initiated, evaluation for complications is performed, family member testing is considered, and follow-up care is established.

The encouraging element of celiac disease diagnosis is that the available tools support accurate diagnosis for the substantial majority of patients. Modern blood tests are highly accurate. Endoscopy with biopsy provides definitive diagnosis when needed. The combination supports effective evaluation.

For most patients suspected of celiac disease, the practical messages are clear. Continue gluten consumption until evaluation is complete. Pursue blood testing followed by biopsy when appropriate. Work with knowledgeable healthcare providers throughout the process. The combination of patient engagement with comprehensive evaluation provides the foundation for accurate diagnosis and the effective management that follows.

⸻

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Individuals should consult a qualified healthcare provider for diagnosis and treatment.